BIT
NWBO

BlackRock Institutional Trust’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History

BlackRock Institutional Trust’s Portfolio NWBO Stock Details NWBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-717,911
Closed -$390K – 3981
2016
Q3 		$390K Hold
717,911
– – ﹤0.01% 3536
2016
Q2 		$417K Sell
717,911
-432,887
-38% -$462K ﹤0.01% 3536
2016
Q1 		$1.68M Buy
1,150,798
+971
+0.1% +$1.92K ﹤0.01% 3109
2015
Q4 		$3.68M Buy
1,149,827
+19,620
+2% +$94.3K ﹤0.01% 2868
2015
Q3 		$7.06M Buy
1,130,207
+218,934
+24% +$2.05M ﹤0.01% 2519
2015
Q2 		$9.05M Buy
911,273
+73,222
+9% +$641K ﹤0.01% 2473
2015
Q1 		$6.18M Buy
838,051
+337,526
+67% +$2.27M ﹤0.01% 2670
2014
Q4 		$2.68M Buy
500,525
+143,963
+40% +$737K ﹤0.01% 2982
2014
Q3 		$1.79M Sell
356,562
-42,849
-11% -$263K ﹤0.01% 3124
2014
Q2 		$2.68M Buy
399,411
+358,528
+877% +$2.28M ﹤0.01% 3058
2014
Q1 		$296K Buy
40,883
+24,623
+151% +$146K ﹤0.01% 3657
2013
Q4 		$61K Buy
+16,260
New +$62.9K ﹤0.01% 3836
2013
Q3 		– Sell
-37,033
Closed -$124K – 4128
2013
Q2 		$124K Buy
+37,033
New +$134K ﹤0.01% 3709

Other funds holding NWBO

WIM
Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return
CDH
Charles D. Hyman $1.79B AUM 17.18% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return
MBT
Montecito Bank & Trust Santa Barbara, California $668M AUM 24.84% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BW
Biegel & Waller Columbia, Maryland $179M AUM 1.6% 1-Year Est. Return
MPI
Mairs & Power Inc St Paul, Minnesota $9.79B AUM 20.6% 1-Year Est. Return

BlackRock Institutional Trust's NWBO Position: Q4 2016 in Review

BlackRock Institutional Trust sold out of Northwest Biotherapeutics, Inc. Common stock (NWBO) in Q4 2016, closing a stake of 717,911 shares — an estimated $390K sold.

BlackRock Institutional Trust first reported a position in NWBO in Q2 2013 and held it in 13 quarters. The position peaked at $9.05M in Q2 2015. 8 funds tracked by Wall St. Rank hold NWBO as of Q4 2016.

  • BlackRock Institutional Trust reported no remaining Northwest Biotherapeutics, Inc. Common stock position as of Q4 2016 after selling out during the quarter.
  • BlackRock Institutional Trust sold 717,911 Northwest Biotherapeutics, Inc. Common stock shares in Q4 2016, an estimated $390K.
  • BlackRock Institutional Trust first reported a position in Northwest Biotherapeutics, Inc. Common stock in Q2 2013 and held it in 13 quarters.
  • BlackRock Institutional Trust's Northwest Biotherapeutics, Inc. Common stock position peaked at $9.05M in Q2 2015.
  • 8 funds tracked by Wall St. Rank held Northwest Biotherapeutics, Inc. Common stock as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.